Financial Ratios Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 21:00:00 18/05/2026 BST			5-day change	1st Jan Change
16.28 ^USD	+3.50%		-5.13%	-17.57%

05-14	Alignment Healthcare, Inc.(NasdaqGS:ALHC) added to S&P 1000	CI
05-14	Alignment Healthcare, Inc.(NasdaqGS:ALHC) added to S&P 600	CI

22cb.4z8TZ7Q0VYqqCFp_-FAfc-FaVYppfoS1FsNzdOnYtU0.mwpBMfpYBMHkXyAsjRxaJIs9GM4CDunPTLcRNYTh0CizaUsMmW4E8O5Dag

Published financial data: ALIGNMENT HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	1.17B	1.43B	1.8B	2.67B	3.91B
Other Revenues, Total	688K	2.61M	22.7M	31.63M	37M
Total Revenues	1.17B	1.43B	1.82B	2.7B	3.95B
Policy Benefits	1.04B	1.25B	1.62B	2.41B	3.46B
Depreciation & Amortization - (IS) - (Collected)	15.81M	17.27M	21.41M	26.27M	29.8M
Selling General & Admin Expenses, Total	291M	296M	306M	369M	442M
Total Operating Expenses	1.35B	1.56B	1.95B	2.8B	3.93B
Operating Income	-178M	-129M	-126M	-97.68M	16.26M
Interest Expense, Total	-17.44M	-18.29M	-21.23M	-23.55M	-15.8M
Other Non Operating Income (Expenses)	229K	-75K	564K	63K	17K
EBT, Excl. Unusual Items	-195M	-147M	-147M	-121M	483K
Restructuring Charges	-	-	-	-2.36M	-
Impairment of Goodwill	-	-	-	-	-600K
Gain (Loss) on Sale of Assets	-	-101K	289K	9K	72K
Asset Writedown	-	-	-	-600K	-
Legal Settlements	-	-	-1.9M	-913K	-913K
Other Unusual Items	-	-2.2M	-	-3.02M	-
EBT, Incl. Unusual Items	-195M	-149M	-148M	-128M	-958K
Income Tax Expense	-	339K	-22K	21K	20K
Earnings From Continuing Operations	-195M	-150M	-148M	-128M	-978K
Net Income to Company	-195M	-150M	-148M	-128M	-978K
Minority Interest	-	92K	156K	36K	254K
Net Income - (IS)	-195M	-150M	-148M	-128M	-724K
Net Income to Common Incl Extra Items	-195M	-150M	-148M	-128M	-724K
Net Income to Common Excl. Extra Items	-195M	-150M	-148M	-128M	-724K
Per Share Items
Net EPS - Basic	-1.14	-0.83	-0.79	-0.67	-0
Basic EPS - Continuing Operations	-1.14	-0.83	-0.79	-0.67	-0
Basic Weighted Average Shares Outstanding	172M	181M	186M	191M	198M
Net EPS - Diluted	-1.14	-0.83	-0.79	-0.67	-0
Diluted EPS - Continuing Operations	-1.14	-0.83	-0.79	-0.67	-0
Diluted Weighted Average Shares Outstanding	172M	181M	186M	191M	198M
Normalized Basic EPS	-0.71	-0.51	-0.49	-0.4	0
Normalized Diluted EPS	-0.71	-0.51	-0.49	-0.4	0
Supplemental Items
EBITDA	-162M	-111M	-104M	-70.62M	46.11M
EBITA	-178M	-128M	-126M	-96.98M	16.26M
EBIT	-178M	-129M	-126M	-97.68M	16.26M
EBITDAR	-158M	-108M	-102M	-67.83M	48.99M
Total Revenues (As Reported)	1.17B	1.43B	1.82B	2.7B	3.95B
Effective Tax Rate - (Ratio)	-	-0.23	0.01	-0.02	-2.09
Normalized Net Income	-122M	-91.78M	-91.46M	-75.69M	556K
Interest on Long-Term Debt	17.44M	18.29M	21.23M	23.55M	15.8M
Supplemental Operating Expense Items
Advertising Expense	3.58M	7.96M	6.96M	5.76M	8.04M
Selling and Marketing Expenses	3.58M	7.96M	6.96M	5.76M	8.04M
Net Rental Expense, Total	3.6M	3.37M	2.68M	2.79M	2.88M
Imputed Operating Lease Interest Expense	3.15M	2.99M	2.67M	2.09M	1.1M
Imputed Operating Lease Depreciation	452K	383K	12.66K	700K	1.78M
Stock-Based Comp., SG&A Exp. (Total)	107M	72.59M	59.29M	66.2M	55.95M
Stock-Based Comp., Other (Total)	15.42M	9.13M	7.54M	4.93M	6.13M
Total Stock-Based Compensation	122M	81.72M	66.84M	71.13M	62.08M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	-	-	116M	37.79M	28.41M
Total investments	-	-	116M	37.79M	28.41M
Cash And Equivalents	467M	410M	203M	433M	576M
Other Receivables - (Insurance Template)	58.51M	92.89M	120M	154M	322M
Gross Property Plant And Equipment	126M	148M	186M	224M	250M
Accumulated Depreciation	-88.2M	-105M	-124M	-149M	-179M
Net Property Plant And Equipment	38.21M	42.99M	61.86M	74.96M	71.27M
Goodwill	29.3M	34.81M	34.83M	34.83M	32.06M
Other Intangibles, Total	5.81M	5.48M	5.25M	4.55M	4.55M
Other Current Assets, Total	27.75M	42.11M	44.97M	37.08M	25.78M
Other Long-Term Assets, Total	4.71M	6.04M	6.4M	6.09M	6.33M
Total Assets	631M	634M	592M	782M	1.07B
Liabilities
Accounts Payable, Total	13.72M	28.09M	20.88M	20M	30.41M
Accrued Expenses, Total	150M	198M	240M	330M	524M
Current Portion of Leases	3.71M	4.2M	1.72M	1.21M	1.96M
Long-Term Debt	151M	161M	162M	321M	323M
Long-Term Leases	6.98M	3.7M	8.97M	7.84M	6.47M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	913K	913K	913K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	325M	395M	434M	681M	887M
Common Stock, Total	188K	187K	189K	192K	205K
Additional Paid In Capital	881M	970M	1.04B	1.11B	1.19B
Retained Earnings	-575M	-732M	-880M	-1.01B	-1.01B
Total Common Equity	306M	238M	157M	99.85M	179M
Minority Interest	15K	1.18M	1.12M	1.1M	-
Total Equity	306M	239M	158M	101M	179M
Total Liabilities And Equity	631M	634M	592M	782M	1.07B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	187M	187M	189M	192M	204M
ECS Total Common Shares Outstanding	187M	187M	189M	192M	204M
Book Value / Share	1.63	1.27	0.83	0.52	0.88
Tangible Book Value	271M	198M	117M	60.48M	143M
Tangible Book Value Per Share	1.45	1.06	0.62	0.32	0.7
Total Debt	161M	169M	173M	330M	332M
Net Debt	-305M	-241M	-30.4M	-102M	-244M
Debt Equivalent Oper. Leases	28.82M	26.99M	21.46M	22.32M	23.03M
Minority Interest, Total (Incl. Fin. Div)	15K	1.18M	1.12M	1.1M	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	13.58M	15.44M	15.84M	16.91M	18.15M
Full Time Employees	847	1.04K	1.54K	1.68K	1.85K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-195M	-150M	-148M	-128M	-724K
Depreciation, Depletion & Amortization	15.67M	17.1M	21.44M	26.36M	29.85M
Amortization of Goodwill and Intangible Assets - (CF)	362K	386K	226K	702K	-
Total Depreciation, Depletion & Amortization	16.03M	17.49M	21.67M	27.06M	29.85M
Amortization of Deferred Charges, Total	2.25M	1.85M	-	1.29M	1.76M
(Gain) Loss On Sale of Asset - (CF)	-	611K	-	134K	-72K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-2.58M	-1.3M
Total Asset Writedown	-	-	-289K	-	634K
Stock-Based Compensation (CF)	111M	81.72M	66.84M	71.13M	62.08M
Provision and Write-off of Bad Debts	111K	150K	91K	123K	833K
Change in Accounts Receivable	-17.61M	-34.38M	-26.95M	-34.28M	-100M
Change in Accounts Payable	437K	13.74M	-6.35M	-1.46M	10.36M
Change in Other Net Operating Assets (Collected)	-2.24M	15.08M	35.32M	96.63M	135M
Other Operating Activities	6.93M	7.86M	-1.5M	4.75M	1.36M
Cash from Operations	-78.78M	-45.43M	-59.19M	34.77M	140M
Capital Expenditure	-19.76M	-23.77M	-36M	-41.42M	-26.78M
Sale of Property, Plant, and Equipment	-	-	-	14K	75K
Cash Acquisitions	-	-4.04M	-	-	-
Divestitures	-	-	-	-	1.06M
Investment in Marketable and Equity Securities, Total	-1.05M	-400K	-111M	80.6M	10.67M
Cash from Investing	-20.82M	-28.22M	-147M	39.19M	-14.97M
Long-Term Debt Issued, Total	-	165M	-	380M	-
Total Debt Issued	-	165M	-	380M	-
Long-Term Debt Repaid, Total	-	-143M	-	-215M	-
Total Debt Repaid	-	-143M	-	-215M	-
Issuance of Common Stock	391M	-	-	155K	18.07M
Repurchase of Common Stock	-1.47M	-	-	-350K	-
Other Financing Activities, Total	-29M	-5.23M	105K	-8.78M	-26K
Cash from Financing	360M	16.59M	105K	156M	18.04M
Net Change in Cash	261M	-57.05M	-206M	230M	143M
Supplemental Items
Cash Interest Paid	10.99M	22.45M	19.16M	22.16M	13.75M
Cash Income Tax Paid (Refund)	-	-	-	-	25K
Net Debt Issued / Repaid	-	21.82M	-	165M	-
Levered Free Cash Flow	-17.13M	-1.07M	-150M	123M	124M
Unlevered Free Cash Flow	-8.48M	8.51M	-136M	137M	133M
Change In Net Working Capital	15.46M	-13.48M	110M	-141M	-57.29M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-22.96	-12.71	-12.84	-8.89	1.1
Return on Total Capital	-33.94	-18.37	-21.31	-16.02	2.16
Return On Equity %	-116.01	-54.88	-74.58	-98.89	-0.7
Return on Common Equity	-116.02	-54.96	-74.93	-99.72	-0.52
Margin Analysis
Gross Profit Margin %	11.02	12.85	11.02	11	12.37
SG&A Margin	24.92	20.61	16.75	13.64	11.21
EBITDA Margin %	-13.88	-7.75	-5.72	-2.61	1.17
EBITA Margin %	-15.22	-8.94	-6.89	-3.59	0.41
EBIT Margin %	-15.25	-8.97	-6.9	-3.61	0.41
Income From Continuing Operations Margin %	-16.72	-10.43	-8.13	-4.74	-0.02
Net Income Margin %	-16.72	-10.43	-8.12	-4.74	-0.02
Net Avail. For Common Margin %	-16.72	-10.43	-8.12	-4.74	-0.02
Normalized Net Income Margin	-10.45	-6.4	-5.02	-2.8	0.01
Levered Free Cash Flow Margin	-1.47	-0.07	-8.2	4.57	3.15
Unlevered Free Cash Flow Margin	-0.73	0.59	-7.47	5.06	3.36
Asset Turnover
Asset Turnover	2.41	2.27	2.98	3.94	4.27
Fixed Assets Turnover	31.04	35.32	34.78	39.52	54.01
Short Term Liquidity
Current Ratio	3.31	2.37	1.84	1.88	1.71
Quick Ratio	3.14	2.18	1.67	1.78	1.66
Operating Cash Flow to Current Liabilities	-0.47	-0.2	-0.23	0.1	0.25
Average Days Payable Outstanding	4.58	6.1	5.51	3.18	2.71
Long Term Solvency
Total Debt/Equity	52.7	70.54	109.13	327.35	184.97
Total Debt / Total Capital	34.51	41.36	52.18	76.6	64.91
LT Debt/Equity	51.49	68.78	108.04	326.15	183.87
Long-Term Debt / Total Capital	33.72	40.33	51.66	76.32	64.52
Total Liabilities / Total Assets	51.49	62.25	73.29	87.09	83.18
EBIT / Interest Expense	-10.21	-7.03	-5.93	-4.15	1.03
EBITDA / Interest Expense	-9.08	-5.89	-4.78	-2.88	3.1
(EBITDA - Capex) / Interest Expense	-10.22	-7.19	-6.48	-4.64	1.41
Total Debt / EBITDA	-1.02	-1.57	-1.7	-4.87	6.77
Net Debt / EBITDA	1.93	2.23	0.3	1.51	-4.98
Total Debt / (EBITDA - Capex)	-0.91	-1.28	-1.25	-3.03	14.93
Net Debt / (EBITDA - Capex)	1.71	1.83	0.22	0.94	-11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	21.74	22.81	27.16	48.25	46.06
Gross Profit, 1 Yr. Growth %	-22.56	43.15	9.09	47.98	64.23
EBITDA, 1 Yr. Growth %	-1.69K	-31.4	-6.21	-33.47	-163.89
EBITA, 1 Yr. Growth %	3.5K	-27.83	-2	-23.99	-116.51
EBIT, 1 Yr. Growth %	3.28K	-27.76	-2.12	-23.58	-116.5
Earnings From Cont. Operations, 1 Yr. Growth %	751.81	-23.37	-0.98	-13.57	-99.24
Net Income, 1 Yr. Growth %	751.81	-23.42	-1.02	-13.5	-99.43
Normalized Net Income, 1 Yr. Growth %	790.9	-24.8	-0.01	-18.3	-100.73
Diluted EPS Before Extra, 1 Yr. Growth %	653.61	-27.33	-3.68	-15.58	-99.46
Net Property, Plant and Equip., 1 Yr. Growth %	3.18	12.52	43.88	21.17	-4.92
Total Assets, 1 Yr. Growth %	86.38	0.47	-6.62	32.13	36.28
Common Equity, 1 Yr. Growth %	899.77	-22.19	-34.09	-36.38	79.54
Tangible Book Value, 1 Yr. Growth %	-6.82K	-26.98	-40.93	-48.25	135.91
Cash From Operations, 1 Yr. Growth %	-1.14K	-42.33	30.29	-158.75	302.44
Capital Expenditures, 1 Yr. Growth %	25.83	20.28	51.4	15.07	-35.34
Levered Free Cash Flow, 1 Yr. Growth %	165.44	-93.77	5.03K	-182.61	1.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-538.31	-200.34	-1.7K	-199.59	-2.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.21	22.28	24.97	37.3	47.15
Gross Profit, 2 Yr. CAGR %	16.06	5.29	24.96	27.06	55.89
EBITDA, 2 Yr. CAGR %	254.4	230.14	-19.79	-20.29	-34.09
EBITA, 2 Yr. CAGR %	146.88	409.74	-15.9	-13.04	-64.3
EBIT, 2 Yr. CAGR %	145.76	394.39	-15.91	-12.86	-64.33
Earnings From Cont. Operations, 2 Yr. CAGR %	108.94	155.48	-12.89	-7.49	-91.88
Net Income, 2 Yr. CAGR %	108.94	155.4	-12.94	-7.47	-93.01
Normalized Net Income, 2 Yr. CAGR %	109.93	158.84	-13.44	-9.19	-92.25
Diluted EPS Before Extra, 2 Yr. CAGR %	85.72	134.01	-16.34	-9.82	-93.22
Net Property, Plant and Equip., 2 Yr. CAGR %	18	7.75	27.24	32.04	7.34
Total Assets, 2 Yr. CAGR %	80.59	36.84	-3.14	11.08	34.19
Common Equity, 2 Yr. CAGR %	97.18	178.91	-28.39	-35.25	6.88
Tangible Book Value, 2 Yr. CAGR %	54.38	600.3	-34.32	-44.71	10.49
Cash From Operations, 2 Yr. CAGR %	192.49	145.11	-13.32	-12.51	53.76
Capital Expenditures, 2 Yr. CAGR %	38.9	23.02	34.95	31.99	-13.74
Levered Free Cash Flow, 2 Yr. CAGR %	-	-59.32	177.75	975.28	-8.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	109.71	300.79	301.04	-1.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	23.74	23.88	32.29	40.16
Gross Profit, 3 Yr. CAGR %	-	24.47	6.54	32.21	38.4
EBITDA, 3 Yr. CAGR %	-	105.01	117.03	-24.18	-25.42
EBITA, 3 Yr. CAGR %	-	63.85	194.2	-18.28	-49.76
EBIT, 3 Yr. CAGR %	-	63.4	188.15	-18.14	-49.81
Earnings From Cont. Operations, 3 Yr. CAGR %	-	49.56	86.27	-13.12	-81.3
Net Income, 3 Yr. CAGR %	-	49.53	86.21	-13.13	-83.08
Normalized Net Income, 3 Yr. CAGR %	-	49.09	88.29	-14.72	-81.77
Diluted EPS Before Extra, 3 Yr. CAGR %	-	35.84	74.07	-16.09	-83.58
Net Property, Plant and Equip., 3 Yr. CAGR %	-	16.14	18.65	25.18	18.35
Total Assets, 3 Yr. CAGR %	-	48.53	20.47	7.42	18.91
Common Equity, 3 Yr. CAGR %	-	44.63	72.43	-31.16	-9.03
Tangible Book Value, 3 Yr. CAGR %	-	20.28	207.13	-39.34	-10.32
Cash From Operations, 3 Yr. CAGR %	-	70.24	98.56	-23.86	45.5
Capital Expenditures, 3 Yr. CAGR %	-	32.39	31.84	27.97	4.05
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	185.09	85.37	388.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	312.92	152.7	149.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	28.99	32.71
Gross Profit, 5 Yr. CAGR %	-	-	-	25.5	24.06
EBITDA, 5 Yr. CAGR %	-	-	-	40.49	35.23
EBITA, 5 Yr. CAGR %	-	-	-	27.17	26.93
EBIT, 5 Yr. CAGR %	-	-	-	27.07	25.32
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	23.41	-46.79
Net Income, 5 Yr. CAGR %	-	-	-	23.41	-49.9
Normalized Net Income, 5 Yr. CAGR %	-	-	-	22.27	-47.32
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	15.31	-52.47
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	22.26	13.99
Total Assets, 5 Yr. CAGR %	-	-	-	32.23	25.78
Common Equity, 5 Yr. CAGR %	-	-	-	4.87	42.41
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-11.86	104.04
Cash From Operations, 5 Yr. CAGR %	-	-	-	30.44	79.25
Capital Expenditures, 5 Yr. CAGR %	-	-	-	32.23	11.26
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	80.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	132.89